Cosmos Health Net Worth
Cosmos Health Net Worth Breakdown | COSM |
Cosmos Health Net Worth Analysis
Cosmos Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Cosmos Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Cosmos Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Cosmos Health's net worth analysis. One common approach is to calculate Cosmos Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Cosmos Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Cosmos Health's net worth. This approach calculates the present value of Cosmos Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Cosmos Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Cosmos Health's net worth. This involves comparing Cosmos Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Cosmos Health's net worth relative to its peers.
Enterprise Value |
|
To determine if Cosmos Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Cosmos Health's net worth research are outlined below:
| Cosmos Health generated a negative expected return over the last 90 days | |
| Cosmos Health has some characteristics of a very speculative penny stock | |
| Cosmos Health has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 53.38 M. Net Loss for the year was (18.54 M) with profit before overhead, payroll, taxes, and interest of 8.33 M. | |
| Cosmos Health currently holds about 322.37 K in cash with (15.64 M) of positive cash flow from operations. | |
| Cosmos Health has a frail financial position based on the latest SEC disclosures | |
| Roughly 16.0% of the company shares are held by company insiders | |
| Latest headline from accesswire.com: Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets |
Cosmos Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Cosmos Health. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Cosmos Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 11th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Know Cosmos Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Cosmos Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cosmos Health backward and forwards among themselves. Cosmos Health's institutional investor refers to the entity that pools money to purchase Cosmos Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Cornerstone Planning Group Llc | 2024-09-30 | 200 | Bank Of America Corp | 2024-06-30 | 122 | Wells Fargo & Co | 2024-06-30 | 0.0 | Fmr Inc | 2024-06-30 | 0.0 | Compagnie Lombard, Odier Sca | 2024-06-30 | 0.0 | Hrt Financial Llc | 2024-06-30 | 0.0 | Armistice Capital, Llc | 2024-09-30 | 1.7 M | Blackrock Inc | 2024-06-30 | 267.8 K | Geode Capital Management, Llc | 2024-09-30 | 149.7 K | Vanguard Group Inc | 2024-09-30 | 134.8 K | State Street Corp | 2024-06-30 | 24.7 K |
Follow Cosmos Health's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 17.37 M.Market Cap |
|
Project Cosmos Health's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.32) | (0.33) | |
| Return On Capital Employed | (0.52) | (0.50) | |
| Return On Assets | (0.28) | (0.29) | |
| Return On Equity | (0.51) | (0.49) |
When accessing Cosmos Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Cosmos Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Cosmos Health's profitability and make more informed investment decisions.
Evaluate Cosmos Health's management efficiency
Cosmos Health has return on total asset (ROA) of (0.2023) % which means that it has lost $0.2023 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5661) %, meaning that it created substantial loss on money invested by shareholders. Cosmos Health's management efficiency ratios could be used to measure how well Cosmos Health manages its routine affairs as well as how well it operates its assets and liabilities. As of the 26th of November 2024, Return On Tangible Assets is likely to drop to -0.33. In addition to that, Return On Capital Employed is likely to grow to -0.5. At this time, Cosmos Health's Asset Turnover is very stable compared to the past year.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 3.01 | 3.16 | |
| Tangible Book Value Per Share | 2.37 | 2.49 | |
| Enterprise Value Over EBITDA | (1.49) | (1.57) | |
| Price Book Value Ratio | 0.47 | 0.49 | |
| Enterprise Value Multiple | (1.49) | (1.57) | |
| Price Fair Value | 0.47 | 0.49 | |
| Enterprise Value | 25.5 M | 22.7 M |
Leadership at Cosmos Health emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Enterprise Value Revenue 0.4471 | Revenue 56.5 M | Quarterly Revenue Growth 0.068 | Revenue Per Share 3.733 | Return On Equity (0.57) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cosmos Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cosmos Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cosmos Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cosmos Health time-series forecasting models is one of many Cosmos Health's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cosmos Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Cosmos Health Earnings per Share Projection vs Actual
When determining whether Cosmos Health is a strong investment it is important to analyze Cosmos Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cosmos Health's future performance. For an informed investment choice regarding Cosmos Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cosmos Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cosmos Health. If investors know Cosmos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cosmos Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.45) | Revenue Per Share 3.733 | Quarterly Revenue Growth 0.068 | Return On Assets (0.20) | Return On Equity (0.57) |
The market value of Cosmos Health is measured differently than its book value, which is the value of Cosmos that is recorded on the company's balance sheet. Investors also form their own opinion of Cosmos Health's value that differs from its market value or its book value, called intrinsic value, which is Cosmos Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cosmos Health's market value can be influenced by many factors that don't directly affect Cosmos Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cosmos Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cosmos Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cosmos Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.